Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 10/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 10/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 4/20 | 0.37 |
| ▸ | SLC11A2 | P49281 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2786628 | 0.82 | GRIN1 (0.38) | GRIN1GRIN2BBACE1BACE2PGR | |
| SCHEMBL2785994 | 0.82 | GRIN1 (0.38) | GRIN1GRIN2BBACE1BACE2PIK3CD | |
| SCHEMBL2786610 | 0.80 | HDAC1 (0.38) | GRIN1GRIN2BPIK3CDSLC11A2PGR | |
| SCHEMBL2785718 | 0.78 | PIM1 (0.39) | GRIN1GRIN2BPIK3CD | |
| SCHEMBL2785099 | 0.78 | EPHX2 (0.42) | GRIN1GRIN2BPIK3CDPGR | |
| SCHEMBL1949290 | 0.77 | GRIN1 (0.43) | GRIN1GRIN2BBACE1BACE2PIK3CD | |
| SCHEMBL2785604 | 0.76 | PGR (0.50) | GRIN1GRIN2BPIK3CDPGR | |
| SCHEMBL2785648 | 0.76 | PIK3CD (0.38) | GRIN1GRIN2BPIK3CDPGR | |
| SCHEMBL2786152 | 0.76 | GRIN1 (0.40) | GRIN1GRIN2BPIK3CDPGR | |
| SCHEMBL3042061 | 0.74 | SLC11A2 (0.44) | GRIN1GRIN2BBACE1BACE2SLC11A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2209373-A1 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-28 | — | — | EP | claimed |
| WO-2009045386-A1 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | claimed |